GlassScriptPhysician profile
Cyril J Schaefer
NPI 1659323103
$358.94
in general payments reported to CMS, 2019-2025
12 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.51 · 2024: $78.41 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $78.11 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $64.27 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $49.54 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.15 | 2024-2025 | Caplyta |
| Inspire Medical Systems, INC. | $21.00 | 2025 | Inspire |
| Abbvie INC. | $19.12 | 2025 | |
| Amgen INC. | $18.01 | 2024 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $16.51 | 2021 | |
| Novo Nordisk INC | $15.86 | 2024 | Ozempic, Rybelsus |
| Teva Pharmaceuticals USA, INC. | $15.61 | 2025 | Austedo Xr |
| Lilly USA, LLC | $15.02 | 2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $14.74 | 2025 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyril Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.